#biocon

किरण मजूमदार-शॉ ने क्लेयर मजूमदार को अपना उत्तराधिकारी बताने वाले एक ट्वीट का जवाब दिया है। बिकारा थेरेप्यूटिक्स की संस्थापक सीईओ क्लेयर, बायोकॉन के संस्थापक और चेयरपर्सन की भतीजी हैं। वह मजूमदार-शॉ के भाई रवि मजूमदार की बेटी हैं। किरण मजूमदार-शॉ और उनकी भतीजी क्लेयर मजूमदार। (एक्स/@किरणशॉ, लिंक्डइन/क्लेयर मजूमदार) जिस ट्वीट से यह सब शुरू हुआ, उसमें किरण मजूमदार-शॉ के बारे में एक लेख शामिल था,…

https://img.etimg.com/thumb/msid-127837576,width-1200,height-630,imgsize-5030,overlay-etmarkets/articleshow.jpg The Union Budget’s announcement of the ₹10,000 crore Biopharma SHAKTI programme has been welcomed by industry leaders as a significant step towards strengthening India’s domestic biopharmaceutical manufacturing and innovation ecosystem. Speaking to ET Now, Biocon Biologics CEO and MD…

Dear Colleagues! This is Asrar Qureshi’s Blog Post #1203 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to [email protected]  for publishing your contributions here. Credit: Google Images Preamble This blog post is based on a McKinsey Future of Asia interview of Ms. Kiran Mazumdar-Shaw, the…

https://img.etimg.com/thumb/msid-123170776,width-1200,height-630,imgsize-23094,overlay-etmarkets/articleshow.jpg Biocon posted a 95% year-on-year decline in reported net profit in the first quarter ended-June. However, the company claims to have on a like-for-like basis booked a 65% increase in profit after tax, after adjusting for the one-time divestment gains it made in the same quarter a year…

https://img.etimg.com/thumb/msid-122864069,width-1200,height-630,imgsize-43168,overlay-etmarkets/articleshow.jpg Syngene International, a subsidiary of Biocon, reported 11% year-on-year increase in its first quarter revenue from operations to Rs 875 crore, while net profit for the period surged 59% to Rs 87 crore. A top company official attributed it to continued conversion of pilot programs…